drug discovery OR stratm
261 Results
Wyszukiwanie zaawansowane
Showing
Zawęź wyniki Użyj poniższych filtrów, aby zawęzić kryteria wyszukiwania
Content by Application
Content by Brand
Content by Industry
-
-
Lead Discovery GPCRs | Life Science Research | Merck
Lead discovery G protein coupled receptors (GPCRs) are prominent drug targets for treating hypertension, pain, asthma, neurological and other disorders -
GPCR Membrane Preparations | Life Science Research | Merck
Our membrane preparations have been pharmacologically validated for competitive radioligand binding and/or GTPγS studies for worry-free GPCR assays. -
Lead Discovery Ion Channels | Life Science Research | Merck
Lead discovery Ion Channels are important therapeutic targets for conditions including arrhythmia, hypertension, local anesthesia, pain, stroke, epilepsy, depression, bipolar disorder, COPD, autoimmune -
Purified Phosphatases | Life Science Research | Merck
Our broad portfolio of purified phosphatases include: PP1, PP2s, and PTPs. All of our enzymes are available in quantities sufficient for high throughput screening. -
HTS Kit Selection Guide | Life Science Research | Merck
Browse our HTS kit selection guide and learn more about our HTRF Class I PI 3-Kinase kits, available in both 4-step and 3-step formats to optimise assay volume and throughput for all screening requirements. -
Purified Kinases | Life Science Research | Merck
We have a broad portfolio of purified kinases that includes more than 390 active, inactive and unactivated kinases, phosphatases and the largest available selection of disease-relevant mutants. -
Lead Discovery Kinases & Phosphatases | Life Science Research | Merck
Lead discovery kinases & phosphatases groups are post-translational modifications that regulate many disease states, including cancer, neurodegenerative diseases, diabetes, pain, autoimmunity, and cardiovascular diseases. -
HTRF® Enzyme Assays | Life Science Research | Merck
HTRF® enzyme assays provide a universal method for assaying all Class I PI3-Kinases, Class II PI3-Kinases, and PIPKINS in a homogeneous 384- or 1536-well format. -
Multi-use Ultrafiltration Systems | Biopharmaceutical Manufacturing | Merck
We understand the critical factors necessary for you to achieve successful concentration and diafiltration with maximum recovery of product. From drug discovery through commercial production, we provide a range of standard and custom systems to meet your needs every step of the way.